Biomagnetics Diagnostics Corporation: Management
Our Team
Clayton M. Hardman, Founder,
President & CEO:
Mr. Hardman, has spent 8 years developing Bio-Spectrum's technology and is
President and CEO. His responsibilities include oversight and supervision of all company
operations and long term strategic planning. Mr. Hardman also was a founder of and remains the sole officer and director of
our subsidiary, Bio-Spectrum, positions he has held since March 1997. Further, since 2000, Mr. Hardman has served as the
Chairman of the Board of Directors of Communicationscom Inc. where his duties included technology review and market research.
Mr. Hardman left active duty service in December 1974 and retired from the U.S. Navy reserves in October 1993. During his naval
career he served as a Navy SEAL.
Dr. Hai Shiene Chen, President and founder of ACGT DNA Technologies Corporation. Stem Cell and Genetic Engineering Advisor, Chinese Corporate Development Consultant
In 1995, Dr. Chen founded ACGT Corporation, which in just four short years became a leader in Canada’s DNA industry. From 1991 to 1996, Dr. Chen was Managing Director for the Canadian Genetic Disease Network’s Core Facility. In 1990, Dr. Chen obtained an MS Degree from the University of Toronto and led a research project on HIV at that institution. Between 1986 and 1988, Dr. Chen trained at Harvard Medical School in the area of cancer research. Dr. Chen was educated at the Second Military Medical University, Shanghai, China. He received his Medical Degree in 1983, graduating in the top 2% of his class.
Dr. Jose Manuel Lopez Portillo, , Director Strategic Alliances & Govn't Affairs Mexico:
Dr. Portillo, a neurosurgeon, held the position of Director of Medical Services of ISSSTE (the social security system for all government employees)
during his cousin's presidency. He has an extensive background in the internal affairs of government regulations of Mexico.
Rear Admiral Udomporn Sompongse (ret.), Director Strategic Alliances and
Government Affairs Thailand:
Prior to retiring he held the position of "Royal AIDE-DE-CAMP TO HIS ROYAL HIGHNESS CROWN PRINCE OF THAILAND".
Admiral Sompongse will represent the Company and oversee BRIA Laboratory while conducting clinical trials in Thailand.
Sanjay Mishra, Ph.D., Physics, Advisor:
To advise the Company on matters of Physics in Thin Film Spectroscopy is Sanjay Mishra, Ph.D. He received his
Masters of Science in Physics from Pittsburgh State University, Pittsburgh, Kansas, and his Ph.D. in Physics from
the University of Missouri in Rolla, Missouri. Dr. Mishra participated in the design and implementation of electron
spin polarization detectors at the Advance Light Source facility, Lawrence Berkeley National Laboratory completing his
third year of postdoctoral research. He currently holds the position of Associate Professor, Dept. of Physics, University of Tennessee, Memphis.
Kuldip Sra, Ph.D., Chemistry, Advisor:
To advise the Company on matters of analytical assay development and drug discovery using chemical combinatorial
peptide libraries synthesis methods is Kuldip Sra, Ph.D. Previously he was engaged in immunodiagnostics development with
Chiron Corporation in Emeryville, California where he served as lead scientist in the development of RIBA!" Assays for
infectious diseases. Dr. Sra has also distinguished himself as a Senior Protein Chemist at Sangstat Medical Department of Protein
Chemistry in Menlo Park, California, where he designed and developed point of care, one step assays for HIV-1/HIV-2, HTLV-I/II and CMV to
include clinical trial and protocols on HTLV-I/II tests. He received a Master of Science degree from Punjab University in India, in Organic Chemistry,
a Master of Science degree and a Ph.D. in Biochemistry from Seton Hall University in So. Orange, New Jersey.
Jaspal Singh Mahal, MS, Microbiology, Advisor:
To advise the Company on matters of Microbiology Jaspal Mahal s education includes a
Masters of Science in Microbiology with a minor in Biochemistry and Immunology. Mr. Mahal left his position as a
research chemist with Boehringer-Mannheim Corporation in the development of homogeneous enzyme assays for the medical
diagnostic industry using CEDIA technology to come to work with Bio-Spectrum. His work accomplishments include the development of
a novel confirmation assay for drugs of abuse, antibody screening and evaluation for immunoassays, and protein/antibody purification and conjugation.
Ninlawan (Pichayayothin) Petcharaburanin, Ph.D., Advisor:
President/CEO and founder of Bangkok R.I.A. (BRIA) Group the largest privately owned laboratory in Thailand. BRIA was founded
in 1989 to provide medical services laboratory diagnostics services to hospitals, clinics and other medical care units. Dr. Pichayayothin currently hold the
position of Vice Chairman The Federation of Thai Industry - Chairman Biotechnology Development .
